Conductive hearing loss (CHL) with a normal otoscopic exam can be difficult to diagnose because routine clinical measures such as audiometric air-bone gaps (ABGs) can identify a conductive component but often cannot distinguish among specific underlying mechanical pathologies (e.g., stapes fixation versus superior canal dehiscence, which may produce similar audiograms). Wideband tympanometry (WBT) is a fast, noninvasive test that can provide additional mechanical information across a broad range of frequencies (200 Hz to 8 kHz). However, WBT metrics are influenced by variations in ear canal geometry and probe placement and can be challenging to interpret clinically. In this study, we extend prior WBT absorbance-based classification work by estimating the middle ear input impedance at the tympanic membrane (ZME), a WBT-derived metric intended to reduce ear canal effects. To estimate ZME, we fit an analog circuit model of the ear canal, middle ear, and inner ear to raw WBT data collected at tympanometric peak pressure (TPP). Data from 27 normal ears, 32 ears with superior canal dehiscence, and 38 ears with stapes fixation were analyzed. A multinomial logistic regression classifier was trained using principal component analysis (retaining 90% variance) and stratified 5-fold cross-validation with regularization. We compared feature sets based on ABGs alone, ABGs combined with absorbance, and ABGs combined with the magnitude of ZME. The combination of ABGs and the magnitude of ZME produced the best performance, achieving an overall accuracy of 85.6% compared to 80.4% for ABGs alone and 78.4% for ABGs combined with absorbance. These results suggest that incorporating model-derived middle ear impedance features with standard audiometric measures (ABGs) can improve automated pathology classification for stapes fixation and superior canal dehiscence.

The authors have declared no competing interest.

This work was supported by the National Institutes of Health (NIH) National Institute on Deafness and Other Communication Disorders (Grant T32 DC000038). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of Massachusetts Eye and Ear gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors.